A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
about
Immunologic aspect of ovarian cancer and p53 as tumor antigen.Effects of dendritic cells transfected with full-length wild-type p53 and stimulated by gastric cancer lysates on immune responseSplit T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.Trial watch: Peptide vaccines in cancer therapyToward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides.Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.HLA Class I Allele Frequencies in Southern Iranian Women with Breast CancerImmunotherapy of head and neck cancer: current and future considerations.CD4+ T helper responses in squamous cell carcinoma of the head and neck.Establishment of Synergistic Chemoimmunotherapy for Head and Neck Cancer Using Peritumoral Immature Dendritic Cell Injections and Low-Dose Chemotherapies.HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses.
P2860
Q54808305-4D1F368A-0310-4F31-9EFD-604C45A0B0DFQ54835185-694F4D71-79F5-41D0-8459-6A23C47165C3Q54896384-0DA3F05F-6646-4668-9918-001C0AC21FF5Q54896390-80A7F145-B76F-4F13-95DD-339BE0B92BB2Q54896471-E2F2132E-E3B6-46CD-A6A0-CDEAD5DE3B5CQ54900714-8CB61978-F808-4223-AAD5-3781F2549574Q54906284-84304B0D-0971-4087-A8E6-50E4A5CAF52DQ54972009-2F1A6577-0FF9-4F0D-B013-74241D59E6D4
P1343
Q24814703-89D42618-602B-4A62-ADA7-6CA6749B7A9FQ28388824-ADC72851-EC81-4FE3-86AE-2D408B9708B2Q33999909-0077DBE5-7922-4D84-8D25-9EE23D30A7D4Q35136043-122C5D90-639C-4892-AB94-A12BD16552CAQ35142669-A305E9FF-0F08-4CB2-AA36-1A8CC81576C1Q36476100-FF73D10F-E6D9-410E-BCCE-A7C04090A4FBQ36973865-57BA0D73-9BF8-4688-9C70-45CE7DD9B978Q37259621-7E7D6D52-60E1-45D3-BF8E-BF02B05347CFQ37350666-27EFDCF0-F3DA-4389-B052-7F8651DEFEE8Q39955461-1569566A-0234-44BF-B72D-4407598CA975Q40020449-E6FB8427-9051-40F2-B1C4-204BC81AD364Q47096374-78A32CC1-5C44-417F-A780-FB1D161ABEB3Q47835567-1D83F385-7D31-4285-A734-64E3FF6B3184
P2860
A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A wild-type sequence p53 pepti ...... rcinomas of the head and neck.
@en
A wild-type sequence p53 pepti ...... rcinomas of the head and neck.
@nl
type
label
A wild-type sequence p53 pepti ...... rcinomas of the head and neck.
@en
A wild-type sequence p53 pepti ...... rcinomas of the head and neck.
@nl
prefLabel
A wild-type sequence p53 pepti ...... rcinomas of the head and neck.
@en
A wild-type sequence p53 pepti ...... rcinomas of the head and neck.
@nl
P2093
P4510
P1476
A wild-type sequence p53 pepti ...... arcinomas of the head and neck
@en
P2093
Chikamatsu K
Takiguchi M
Whiteside TL
P304
P407
P577
2000-03-01T00:00:00Z